Category Archives: Medtronic

Cash Advances Are Now Available on Settled Medtronic Infuse Cases

TriMark Legal Funding LLC Now Offers Lawsuit Cash Advances on Settled Medtronic Infuse Cases

TriMark has offered non-recourse lawsuit cash advances on pending Medtronic Infuse lawsuits for years. Now that these cases have begun to settle, TLFLLC is proud to offer settled case funding to plaintiffs awaiting their settlement checks. We can fund up to 50% of an anticipated net settlement (or any lesser amount you may need) and we have low, non-compounding rates on settled case. If you have a Medtronic case that is part of one of the recent settlements, call and speak to one of TriMark’s friendly representatives today at (877) 932-2628 or take 1 minute and apply online now.

Medtronic Pays $50.9M to Settle Three Federal Cases

Medical device maker Medtronic this week resolved three separate cases with the United States Department of Justice — two of which were cases against companies it acquired. In total, Medtronic will pay $50.9 million in settlements, for problems with a … Read more

Medtronic to pay $31M in DoJ settlement of medical device probes

Two companies now owned by Medtronic agree to pay $31M to resolve a U.S. Department of Justice probe into the marketing of a medical device meant to treat a vascular defect in the brain for unapproved purposes and paying kickbacks to hospitals to get them … Read more

Medtronic units to pay $31 mln to resolve U.S. medical device probes

As part of the settlement announced by the U.S. Justice Department on Tuesday, ev3 Inc, a medical device manufacturer now owned by Medtronic, has agreed to plead guilty to a charge related to a neurovascular medical device. Federal prosecutors in Boston … Read more

Supreme Court sets high bar for medical device lawsuits

The U.S. Supreme Court ruled in favor of Medtronic, among the world’s largest makers of medical devices, setting a precedent that has killed lawsuits involving some of the most sophisticated devices on the market. WHAT DID THE SUPREME COURT DECISION DO? Read more

Medtronic agrees to settlement with five states in Infuse case

Medtronic has agreed to pay $12 million to five states to resolve a lawsuit that accuses the medical device company of misleading doctors and the public about the safety of a controversial bone-growth product that has been blamed for thousands of patient … Read more

UPDATE 2-Medtronic settles states’ probe into Infuse marketing for $12 mln

Massachusetts Attorney General Maura Healey said the settlement will resolve an investigation by her office and those in four other states related to Medtronic’s promotion of Infuse, which is used to stimulate bone growth. In court papers, Healey alleged … Read more

Medtronic settles whistleblower lawsuit for $9.9M

FRIDLEY, Minn. • Medical device maker Medtronic Inc. will pay the U.S. Department of Justice $9.9 million to settle a lawsuit that accused the company of giving doctors gifts in return for using its defibrillators and pacemakers. Medtronic has not …

Read more

2 Medtronic’s Infuse Patients To Get $8.45 Million in Settlements

Patients who received Medtronic’s Infuse product to get $8.45 million in settlements

http://www.startribune.com/patients-who-received-medtronic-product-to-get-8-45-million-in-settlements/388947831/Two patients who were injured by Medtronic’s controversial Infuse bone graft product will receive a combined $8.45 million in settlements with the University of California Los Angeles, where a doctor with financial ties to the company used the product …

Original report

Medtronic Disentangles From Durrani Infuse Lawsuits

https://ryortho.com/breaking/medtronic-disentangles-from-durrani-infuse-lawsuits/Spine patients in Ohio who had back surgery performed by federal fugitive, Atiq Durrani M.D., joined together to sue Medtronic because Durrani used Infuse in an alleged off-label fashion.

Durrani is currently practicing back surgery on Pakistanis after …

Original report

Regents OK $8.5 million for 2 patients suing over financial conflicts

http://www.latimes.com/business/la-fi-ucla-wang-medtronics-20160729-snap-story.htmlThe University of California regents have agreed to pay nearly $8.5 million to settle two lawsuits alleging that a well-known UCLA spine surgeon failed to …

Original report

In letter to Franken, FDA defends handling of Medtronic’s Infuse study

http://www.startribune.com/in-letter-to-franken-fda-defends-handling-of-medtronic-s-infuse-study/384052101/After receiving the FDA’s response to his questions, Franken says the handling of Medtronic’s Infuse study signals a broader need to change how the agency safeguards the public’s health.

He called for “a more robust, proactive medical device …

Original report

Sen. Franken pushes for review of Medtronic Infuse study

http://www.massdevice.com/sen-franken-pushes-review-medtronic-infuse-study/Medtronic InFuse Senator Al Franken (D-Minn.) is pushing for more details on Medtronic’s (NYSE:MDT) study of its Infuse Bone Graft, saying that the product …

Original report

New Developments in the Medtronic Infuse Litigation

St. Louis court clears way for first Infuse jury trial

A St. Louis judge has cleared the way for the first jury trial involving personal injuries allegedly caused by Medtronic’s Infuse Bone Graft.

The injury claims of plaintiff Trisha Keim are set for trial in February, after Judge Mark H. Neill of …

Original article here

Patients who received Medtronic’s Infuse product to get $8.45 million in settlements

http://www.startribune.com/patients-who-received-medtronic-product-to-get-8-45-million-in-settlements/388947831/Two patients who were injured by Medtronic’s controversial Infuse bone graft product will receive a combined $8.45 million in settlements with the University of California Los Angeles, where a doctor with financial ties to the company used the product …

Click here for the original post

In letter to Franken, FDA defends handling of Medtronic’s Infuse study

After receiving the FDA’s response to his questions, Franken says the handling of Medtronic’s Infuse study signals a broader need to change how the agency safeguards the public’s health.

He called for “a more robust, proactive medical device …

Original article here

FDA hearing on off-labels use of devices explores risks to patients

First, health policy expert Diana Zuckerman displayed huge photos of the disfigured, bruised faces of two babies who had been implanted with Medtronic’s Infuse Bone Graft product in their skulls.

Then Zuckerman, who is president of the National Center …

See the original post

Ohio judge dismisses hundreds of off-label Medtronic Infuse patient lawsuits

http://www.orthospinenews.com/ohio-judge-dismisses-hundreds-of-off-label-medtronic-infuse-patient-lawsuits/US district court judge, Timothy S Black (Southern Ohio, USA) has dismissed the accusation of several hundred plaintiffs that they have been treated off-label with Medtronic’s Infuse.

The plaintiffs were all former patients of Atiq Durrani …

The original story is here

Medtronic Disentangles Itself From Durrani Infuse Lawsuits

https://ryortho.com/breaking/medtronic-disentangles-from-durrani-infuse-lawsuits/Spine patients in Ohio who had back surgery performed by federal fugitive, Atiq Durrani M.D., joined together to sue Medtronic because Durrani used Infuse in an alleged off-label fashion.

Durrani is currently practicing back surgery on Pakistanis after …

Full article

Court Denies All Medtronic Summary Requests in Infuse Litigation

Parker Waichman LLP notes a significant loss for medical device manufacturer, Medtronic, Inc.

Judge Mark H. Neill of St. Louis’ 22nd Judicial Circuit has ruled that the company’s Infuse medical device may have been …

Read the original article here

Medtronic headaches resurface as patients awarded $8.45 Million

http://southeastpennsylvania.legalexaminer.com/medical-devices-implants/problems-resurface-for-medtronic-as-patients-awarded-8-45-million/This past month marks a pivotal decision in the ongoing litigation over the Medtronic bone graft product, Infuse, as two patients injured by Medtronic’s product will receive a combined $8.45 million in settlements—not from the manufacturers of the …

Read the original article here

A look behind the Star Tribune’s special report on Medtronic, ‘A Question of Risk’

https://www.minnpost.com/media/2016/04/look-behind-star-tribunes-special-report-medtronic-question-riskThe Sunday before last, the Star Tribune published a front-page story laying out how Medtronic, one the area’s highest profile corporations, “misfiled” a report on adverse reactions to the company’s lucrative but problematic bone fusion device, Infuse.

Read the full story here

Sen. Franken pushes for review of Medtronic Infuse study – Mass Device

http://www.massdevice.com/sen-franken-pushes-review-medtronic-infuse-study/Medtronic InFuse Senator Al Franken (D-Minn.) is pushing for more details on Medtronic’s (NYSE:MDT) study of its Infuse Bone Graft, saying that the product may have “potentially skewed the risk profile” for patients and exposed “insufficient vigilance …

The full original post can be seen here